Adicet Bio, Inc. (ACET) Free cash flow 2017–2025
Adicet Bio, Inc. (ACET) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$97.0MFY2025 · since FY2017: -$11.0M → -$97.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.0M | -3.7% |
| FY2024 | -$93.5M | +4.8% |
| FY2023 | -$98.2M | -59.5% |
| FY2022 | -$61.5M | +4.0% |
| FY2021 | -$64.1M | -50.7% |
| FY2020 | -$42.5M | -46.9% |
| FY2019 | -$29.0M | -51.9% |
| FY2018 | -$19.1M | -72.8% |
| FY2017 | -$11.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice